The US cryptocurrency derivatives market is once again embroiled in regulatory controversy. CME Group announced plans to file a lawsuit against the Commodity Futures Trading Commission (CFTC) for approving Bitcoin perpetual contracts. This means that perpetual contracts, long dominated by offshore platforms, are now facing legal challenges from traditional futures giants after entering the regulated US market.
The controversy centers on the product's characterization.
Outgoing CME CEO Terry Duffy told CNBC that the company will file a lawsuit on Thursday. Reuters subsequently confirmed this arrangement, citing CME.
CME's core argument is that Bitcoin perpetual contracts do not fall under the category of traditional futures, but should be classified as swaps under the Dodd-Frank Act. If this determination holds true, related products will be subject to a different set of regulatory requirements regarding clearing, information disclosure, and trading venues.
Unlike regular futures contracts, perpetual contracts do not have a fixed expiration date. They primarily rely on the periodic payment of funding rates between the trading parties to maintain price stability. Therefore, whether they legally qualify as futures contracts has been a matter of concern in the US market.
The CFTC previously approved two related arrangements.
The controversy stems from the CFTC's approval of two perpetual contract-related business transactions at the end of May.
- Kalshi Approved to Launch Bitcoin Perpetual Futures Contracts
- Coinbase has been granted permission to connect offshore perpetual contract products to US customers.
- This marks the first time such a product has been introduced into a regulated trading channel within the United States.
Perpetual contracts have long been among the most liquid derivatives in the crypto market, but have been largely concentrated on platforms outside the United States. CFTC Chairman Michael Selig previously defended this decision, arguing that it would help bring some of the most active trading in the crypto market back to the U.S. regulatory system.
However, CME believes that regulatory approval for this new product is faster than the usual process. Duffy also mentioned that CME holds exclusive licenses for key market benchmarks, suggesting that even if competitors launch similar products, they will find it difficult to completely bypass CME's market infrastructure.
High leverage risk has also become a point of contention.
Perpetual contracts typically support high leverage, with some products mentioned in the text offering leverage as high as 50 times. This design amplifies both gains and losses, making them long considered high-risk derivatives.
Duffy recently publicly criticized the current speculative environment, saying that some market conditions reminded him of the period leading up to the 2008 financial crisis. He believes that the expansion of market prediction and highly leveraged trading may lead to a new accumulation of risks.
The CFTC has not backed down. A spokesperson for the agency told Reuters that the CFTC looks forward to responding to the claims in court and pushing for the dismissal of this "baseless" lawsuit.
Additional information:On the same day, CME also announced management transition arrangements. Duffy will step down in March 2027, and current President and Chief Financial Officer Lynne Fitzpatrick will succeed her as CEO, becoming CME's first female CEO.
